You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Vitamin K Antagonist Treatment in Patients With Atrial Fibrillation and Time in Therapeutic Range in Four European Countries
|
---|---|
Published in |
Clinical Therapeutics, August 2014
|
DOI | 10.1016/j.clinthera.2014.07.016 |
Pubmed ID | |
Authors |
François-Emery Cotté, Hicham Benhaddi, Isabelle Duprat-Lomon, Adam Doble, Nick Marchant, Alexia Letierce, Michael Huguet |
Abstract |
Patients with atrial fibrillation are at increased risk for stroke and thus require anticoagulant prophylaxis with vitamin K antagonists. However, many such patients fail to achieve target coagulation status. The objective of this study was to evaluate time in the therapeutic range and its relationship to clinical outcomes in patients with nonvalvular atrial fibrillation prescribed a vitamin K antagonist in everyday clinical practice in 4 European countries (France, Germany, Italy and the United Kingdom). |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Science communicators (journalists, bloggers, editors) | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 104 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Slovenia | 1 | <1% |
Unknown | 103 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 21 | 20% |
Student > Bachelor | 11 | 11% |
Student > Master | 9 | 9% |
Student > Ph. D. Student | 8 | 8% |
Student > Postgraduate | 8 | 8% |
Other | 23 | 22% |
Unknown | 24 | 23% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 39 | 38% |
Pharmacology, Toxicology and Pharmaceutical Science | 6 | 6% |
Nursing and Health Professions | 3 | 3% |
Agricultural and Biological Sciences | 3 | 3% |
Computer Science | 3 | 3% |
Other | 14 | 13% |
Unknown | 36 | 35% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 September 2021.
All research outputs
#7,959,659
of 25,373,627 outputs
Outputs from Clinical Therapeutics
#1,106
of 3,850 outputs
Outputs of similar age
#73,498
of 247,547 outputs
Outputs of similar age from Clinical Therapeutics
#12
of 56 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 3,850 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.2. This one has gotten more attention than average, scoring higher than 67% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 247,547 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.
We're also able to compare this research output to 56 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.